Regenerative Medical Technology Group Inc. Convertible Notes Payable, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-08-19
- 2026-06-30: Convertible Notes Payable, Current $2.15M.
- 2026-03-31: Convertible Notes Payable, Current $47.45K.
- 2025-12-31: Convertible Notes Payable, Current $2.15M; Convertible Notes Payable, Current as first filed $47.45K.
- 2025-09-30: Convertible Notes Payable, Current $43.14K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.15M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $47.45K 10-Q · filed 2026-06-09 | |
| 2025-12-31 | $2.15M 10-Q · filed 2026-08-19 | $47.45K 10-K · filed 2026-05-14 |
| 2025-09-30 | $43.14K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $43.14K 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $43.14K 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $43.14K 10-K · filed 2026-05-14 | |
| 2021-06-30 | $148.25K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $148.25K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $148.25K 10-Q · filed 2021-08-13 | |
| 2020-11-30 | $4.75K 10-K · filed 2022-05-05 | |
| 2020-09-30 | $2.47M 10-Q · filed 2021-02-24 | |
| 2020-07-15 | $4.12K 10-K · filed 2022-05-05 | |
| 2020-06-30 | $2.02M 10-Q · filed 2021-02-08 | |
| 2020-05-19 | $3.29K 10-K · filed 2022-05-05 | |
| 2020-03-31 | $1.64M 10-Q · filed 2021-01-07 | |
| 2019-12-31 | $1.27M 10-K · filed 2021-04-13 | |
| 2018-12-31 | $812.83K 10-K · filed 2020-12-09 |